Gene · 8658
Papers2,155
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,155
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| New insights from GWAS on BMI-related growth traits in a longitudinal cohort of admixed children with Native American and European ancestry. | iScience | 2023 | 36844456 | PubTator, text mining | PubMed |
| ADP-Ribosylation in Antiviral Innate Immune Response. | Pathogens | 2023 | 36839575 | PubTator, text mining | PubMed |
| Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC. | Int J Mol Sci | 2023 | 36835536 | PubTator, text mining | PubMed |
| In Silico Identification and Functional Characterization of Genetic Variations across DLBCL Cell Lines. | Cells | 2023 | 36831263 | PubTator, text mining | PubMed |
| Aging, Physical Exercise, Telomeres, and Sarcopenia: A Narrative Review. | Biomedicines | 2023 | 36831134 | PubTator, text mining | PubMed |
| The Exciting Realities and Possibilities of iPS-Derived Cardiomyocytes. | Bioengineering (Basel) | 2023 | 36829731 | PubTator, text mining | PubMed |
7S,15R-Dihydroxy-16S,17S-epoxy-docosapentaenoic Acid Overcomes Chemoresistance of 5-Fluorouracil by Suppressing the Infiltration of Tumor-Associated Macrophages and Inhibiting the Activation of Cancer Stem Cells in a Colorectal Cancer Xenograft Model. | Mar Drugs | 2023 | 36827121 | PubTator, text mining | PubMed |
| Ubiquitin specific peptidases and prostate cancer. | PeerJ | 2023 | 36811009 | PubTator, text mining | PubMed |
| Venadaparib Is a Novel and Selective PARP Inhibitor with Improved Physicochemical Properties, Efficacy, and Safety. | Mol Cancer Ther | 2023 | 36808277 | PubTator, text mining | PubMed |
| Impaired neurogenesis and neural progenitor fate choice in a human stem cell model of SETBP1 disorder. | Mol Autism | 2023 | 36805818 | PubTator, text mining | PubMed |
| VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry. | Cell Death Dis | 2023 | 36797281 | PubTator, text mining | PubMed |
| DNA Damage Response Mechanisms in Head and Neck Cancer: Significant Implications for Therapy and Survival. | Int J Mol Sci | 2023 | 36769087 | PubTator, text mining | PubMed |
| Beyond Pellagra-Research Models and Strategies Addressing the Enduring Clinical Relevance of NAD Deficiency in Aging and Disease. | Cells | 2023 | 36766842 | PubTator, text mining | PubMed |
| TRAF4-mediated ubiquitination-dependent activation of JNK/Bcl-xL drives radioresistance. | Cell Death Dis | 2023 | 36765039 | PubTator, text mining | PubMed |
| New molecular insights for 4H-1,2,4-triazole derivatives as inhibitors of tankyrase and Wnt-signaling antagonist: a molecular dynamics simulation study. | J Biomol Struct Dyn | 2023 | 36755438 | PubTator, text mining | PubMed |
| ASPP2 suppresses tumour growth and stemness characteristics in HCC by inhibiting Warburg effect via WNT/β-catenin/HK2 axis. | J Cell Mol Med | 2023 | 36752127 | PubTator, text mining | PubMed |
| In silico analysis of TUBA4A mutations in Amyotrophic Lateral Sclerosis to define mechanisms of microtubule disintegration. | Sci Rep | 2023 | 36747013 | PubTator, text mining | PubMed |
| Patient-derived cell-based pharmacogenomic assessment to unveil underlying resistance mechanisms and novel therapeutics for advanced lung cancer. | J Exp Clin Cancer Res | 2023 | 36717865 | PubTator, text mining | PubMed |
| Transferrin Receptor-Mediated Iron Uptake Promotes Colon Tumorigenesis. | Adv Sci (Weinh) | 2023 | 36703617 | PubTator, text mining | PubMed |
| A phenome-wide comparative analysis of genetic discordance between obesity and type 2 diabetes. | Nat Metab | 2023 | 36703017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8658/papers?page=15